Here, as we expected, using this immunocompetent model, we showed that anti-PD-L1 can activate CD8+ T cells both in the metastatic tumor lesion in brain and its tumor-draining lymph nodes, suggesting that the cancer immunity cycle, including the affiliated lymph nodes, is functioning also in metastatic brain tumors. Here, CD8A is linked to cancer.